Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 670 participants.

Also called NCT04511468

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 670 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04511468
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04511468. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-23 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
Acronym
CHANGE
Condition
PreDiabetes
Condition
Nutrition
Intervention (Dietary supplement)
Zinc, Chromium, Vitamin C, and Copper Supplementation
Intervention (Behavioral)
Standard healthy lifestyle intervention
Intervention (Other)
Placebo
Lead sponsor
Universitas Indonesia (class: other)
Collaborator
Blackmores Institute (class: industry)

Record details

Record id
cardio:ct-nct04511468
Content hash
245d82dcd3ef87c221176bfa2d9a48b461106367cb858f9d9c193b8ef1d5c9da